KDM3B is the H3K9 demethylase involved in transcriptional activation of lmo2 in leukemia

Molecular and Cellular Biology

Volumn 32, Issue 14, 2012, Pages 2917-2933

  Kim, Ji Young ^a   Kim, Kee Beom ^a   Eom, Gwang Hyeon ^b   Choe, Nakwon ^b   Kee, Hae Jin ^b   Son, Hye Ju ^a   Oh, Si Taek ^a   Kim, Dong Wook ^c   Pak, Jhang Ho ^d   Baek, Hee Jo ^b   Kook, Hoon ^b   Hahn, Yoonsoo ^a   Kook, Hyun ^b   Chakravarti, Debabrata ^e   Seo, Sang Beom ^a  

^a Chung Ang University   (South Korea)

^b Chonnam National University   (South Korea)

^c Chonbuk National University   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; LEUKEMIA; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE LMO2; PRIORITY JOURNAL; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; CELL DIFFERENTIATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, LEUKEMIC; HEK293 CELLS; HISTONE ACETYLTRANSFERASES; HISTONES; HL-60 CELLS; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; K562 CELLS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LIM DOMAIN PROTEINS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; TRANSCRIPTIONAL ACTIVATION; TRETINOIN;

EID: 84864014101     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00133-12     Document Type: Article

References (32)

1. Bilodeau S, Kagey MH, Frampton GM, Rahl PB, Young RA. 2009. SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev. 23:2484 -2489.
2. Blobel GA. 2002. CBP and p300: versatile coregulators with important roles in hematopoietic gene expression. J. Leukoc. Biol. 71:545-556.
3. Chatterjee D, et al. 1997. Monocytic differentiation of HL-60 promyelocytic leukemia cells correlates with the induction of Bcl-xL. Cell Growth Differ. 8:1083-1089.
4. Cho YW, et al. 2007. PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J. Biol. Chem. 282:20395- 20406.
5. Cloos PA, et al. 2006. The putative oncogene GASC1 demethylates triand dimethylated lysine 9 on histone H3. Nature 442:307-311.
6. Czvitkovich S, et al. 2001. Over-expression of the SUV39H1 histone methyltransferase induces altered proliferation and differentiation in transgenic mice. Mech. Dev. 107:141-153.
7. Dawson MA, et al. 2009. JAK2 phosphorylates histone H3Y41 and excludes HP1_ from chromatin. Nature 461:819-822.
8. Feldman N, et al. 2006. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 8:188 -194.
9. Golub TR, et al. 1999. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531-537.
10. Hayami S, et al. 2010. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Mol. Cancer 9:59.
11. He J, Nguyen AT, Zhang Y. 2011. KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia. Blood 117:3869 -3880.
12. Hsia DA, et al. 2010. KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 107:9671-9676.
13. Hu X, et al. 2009. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc. Natl. Acad. Sci. U. S. A. 106: 10141-10146.
14. Hu Z, et al. 2001. A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31. Oncogene 20:6946-6954.
15. Kim SM, et al. 2010. Regulation of mouse steroidogenesis by WHISTLE and JMJD1C through histone methylation balance. Nucleic Acids Res. 38:6389-6403.
16. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128:693-705.
17. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410:116 -120.
18. Landry JR, et al. 2005. Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells. Blood 106:2680 -2687.
19. Lee MG, et al. 2007. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318:447- 450.
20. Nam CH, et al. 2008. An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions. Oncogene 27:4962-4968.
21. Okada Y, Scott G, Ray MK, Mishina Y, Zhang Y. 2007. Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis. Nature 450:119 -123.
22. Rea S, et al. 2000. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406:593-599.
23. Rhodes DR, et al. 2004. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6:1- 6.
24. Saleque S, Kim J, Rooke HM, Orkin SH. 2007. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol. Cell 27:562-572.
25. Tachibana M, Nozaki M, Takeda N, Shinkai Y. 2007. Functional dynamics of H3K9 methylation during meiotic prophase progression. EMBO J. 26:3346 -3359.
26. Tateishi K, Okada Y, Kallin EM, Zhang Y. 2009. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458: 757-761.
27. Villa R, et al. 2007. Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. Cancer Cell 11:513-525.
28. Visvader JE, Mao X, Fujiwara Y, Hahm K, Orkin SH. 1997. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. Proc. Natl. Acad. Sci. U. S. A. 94: 13707-13712.
29. Wang Z, et al. 2009. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138:1019 -1031.
30. Warren AJ, et al. 1994. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78:45-57.
31. Yamane K, et al. 2006. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125:483- 495.
32. Yang C, Shapiro LH, Rivera M, Kumar A, Brindle PK. 1998. A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol. Cell. Biol. 18:2218 -2229.